Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

Venous thromboembolism prophylaxis in patients with traumatic brain injury.

Zakrison TL, Pereira BM, Marttos AC Jr, Fraga GP, Nascimento B Jr, Rizoli S.

Rev Col Bras Cir. 2012 Dec;39(6):553-7. English, Portuguese.

2.

Safety and efficacy of early pharmacological thromboprophylaxis in traumatic brain injury: systematic review and meta-analysis.

Jamjoom AA, Jamjoom AB.

J Neurotrauma. 2013 Apr 1;30(7):503-11. doi: 10.1089/neu.2012.2584. Epub 2013 Mar 21. Review.

PMID:
23517138
3.

Low molecular weight heparin: current evidence for its application in orthopaedic surgery.

Kalyani BS, Roberts CS.

Curr Vasc Pharmacol. 2011 Jan;9(1):19-23. Review.

PMID:
21044028
4.

Asian venous thromboembolism guidelines: prevention of venous thromboembolism.

Liew NC, Chang YH, Choi G, Chu PH, Gao X, Gibbs H, Ho CO, Ibrahim H, Kim TK, Kritpracha B, Lee LH, Lee L, Lee WY, Li YJ, Nicolaides AN, Oh D, Pratama D, Ramakrishnan N, Robless PA, Villarama-Alemany G, Wong R; Asian Venous Thrombosis Forum.

Int Angiol. 2012 Dec;31(6):501-16. Review.

PMID:
23222928
5.
6.

Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.

Kanaan AO, Silva MA, Donovan JL, Roy T, Al-Homsi AS.

Clin Ther. 2007 Nov;29(11):2395-405. Review.

PMID:
18158080
7.

Venous thromboembolism in cancer patients undergoing major surgery.

Osborne NH, Wakefield TW, Henke PK.

Ann Surg Oncol. 2008 Dec;15(12):3567-78. doi: 10.1245/s10434-008-0151-4. Epub 2008 Oct 8. Review.

PMID:
18841419
8.

Assessing, preventing, and treating venous thromboembolism: evidence-based approaches.

Nutescu EA.

Am J Health Syst Pharm. 2007 Jun 1;64(11 Suppl 7):S5-13. Review.

PMID:
17519445
9.

Clinical use of parnaparin in major and minor orthopedic surgery: a review.

Bugamelli S, Zangheri E, Montebugnoli M, Guerra L.

Vasc Health Risk Manag. 2008;4(5):983-90. Review.

10.

Long-term use of different doses of low-molecular-weight heparin versus vitamin K antagonists in the treatment of venous thromboembolism.

Romera-Villegas A, Cairols-Castellote MA, Vila-Coll R, Martí-Mestre X, Colomé E, Iguaz I.

Ann Vasc Surg. 2010 Jul;24(5):628-39. doi: 10.1016/j.avsg.2009.08.006. Epub 2009 Nov 25. Review.

PMID:
19932949
11.

Bemiparin: second-generation, low-molecular-weight heparin for treatment and prophylaxis of venous thromboembolism.

Martínez-González J, Vila L, Rodríguez C.

Expert Rev Cardiovasc Ther. 2008 Jul;6(6):793-802. doi: 10.1586/14779072.6.6.793. Review.

PMID:
18570617
12.

Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer.

Akl EA, Vasireddi SR, Gunukula S, Barba M, Sperati F, Terrenato I, Muti P, Schünemann H.

Cochrane Database Syst Rev. 2011 Apr 13;(4):CD006649. doi: 10.1002/14651858.CD006649.pub4. Review. Update in: Cochrane Database Syst Rev. 2011;(6):CD006649.

PMID:
21491395
13.

Role of palliative low-molecular-weight heparin for treating venous thromboembolism in patients with advanced cancer.

Tran QN.

Am J Hosp Palliat Care. 2010 Sep;27(6):416-9. doi: 10.1177/1049909110361244. Epub 2010 Mar 2. Review.

PMID:
20197558
14.

Risk assessment and prophylaxis of venous thromboembolism in acutely and/or critically ill patients.

Davidson BL.

Haemostasis. 2000;30 Suppl 2:77-81; discussion 63. Review.

PMID:
11251346
15.

Low-molecular-weight heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review.

Ribic C, Lim W, Cook D, Crowther M.

J Crit Care. 2009 Jun;24(2):197-205. doi: 10.1016/j.jcrc.2008.11.002. Epub 2009 Feb 7. Review.

PMID:
19327323
16.

Prevention of venous thromboembolism in the cancer surgery patient.

Spyropoulos AC, Brotman DJ, Amin AN, Deitelzweig SB, Jaffer AK, McKean SC.

Cleve Clin J Med. 2008 Apr;75 Suppl 3:S17-26. Review.

PMID:
18496913
17.

[Thoughts about thromboembolic events prophylaxis in cancer patients].

Pikó B, Kremer IM, Rahoty P, Bassam A, Dimák S, Kis A, Csiffári M, Rus-Gal P, Szabó Z, Veréb B, Zsilak J.

Magy Onkol. 2011 Sep;55(3):164-9. doi: MagyOnkol.2011.55.3.164. Epub 2011 Feb 21. Review. Hungarian.

18.

Venous thromboembolism in cancer patients: expanding horizons.

Bergqvist D.

Semin Thromb Hemost. 2002 Aug;28 Suppl 3:19-23. Review.

PMID:
12232819
19.

Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism.

Andras A, Sala Tenna A, Crawford F.

Cochrane Database Syst Rev. 2012 Oct 17;10:CD002001. doi: 10.1002/14651858.CD002001.pub2. Review.

PMID:
23076894
20.

Venous thromboembolism prophylaxis and treatment in patients with acute stroke and traumatic brain injury.

Vergouwen MD, Roos YB, Kamphuisen PW.

Curr Opin Crit Care. 2008 Apr;14(2):149-55. doi: 10.1097/MCC.0b013e3282f57540. Review.

PMID:
18388676

Supplemental Content

Support Center